Emili Montserrat

34.1k citations
296 papers · 16.3k indexed · 5 hit papers · h-index 66
Topics
Chronic Lymphocytic Leukemia Research (165 papers)Lymphoma Diagnosis and Treatment (144 papers)Immunodeficiency and Autoimmune Disorders (58 papers)
Partner nations
SpainItalyUnited States

In The Last Decade

Emili Montserrat

291 papers receiving 15.9k citations

Hit Papers

Guidelines for the diagnosis and treatment of chronic lym...20032026201020182008201820032015202050010001.5k2.0k

Peers

Emili Montserrat
Comparison fields: 5 of 134
  • Genetics 10.5k
  • Pathology and Forensic Medicine 9.4k
  • Immunology 5.3k
  • Oncology 4.1k
  • Hematology 3.8k
Replace Steven P. Treon with:
Steven P. Treon United States
Ian W. Flinn United States
Jan A. Burger United States
Richard R. Furman United States
Stephan Stilgenbauer Germany
Alessandra Ferrajoli United States
Charles Koller United States
Paolo Ghia Italy
Peter Hillmen United Kingdom
Pier Luigi Zinzani Italy
Emili Montserrat relative to Steven P. Treon United States Steven P. Treon's profile →
Citations per field
00.5×1.5×
Steven P. Treon · 1×
Citations per year

Countries citing papers authored by Emili Montserrat

Since Specialization
Citations

This map shows the geographic impact of Emili Montserrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emili Montserrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emili Montserrat more than expected).

Fields of papers citing papers by Emili Montserrat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emili Montserrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emili Montserrat. The network helps show where Emili Montserrat may publish in the future.

Co-authorship network of co-authors of Emili Montserrat

This figure shows the co-authorship network connecting the top 25 collaborators of Emili Montserrat. A scholar is included among the top collaborators of Emili Montserrat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emili Montserrat. Emili Montserrat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 14
2 5
3 21
4 39
5 66
6 3
7 133
8 246
9 60
10 95
11
The purine nucleoside phosphorylase inhibitor forodesine induces p53-independent apoptosis in chronic lymphocytic leukemia through caspase-8 activation, Mcl-1 downregulation, conformational changes of Bax and Bak and ROS generation.
2
12 69
13 91
14
Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.
51
15 89
16 11
17 143
18 4
19 13
20 13

About Emili Montserrat

Emili Montserrat is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 296 papers that have together received 16.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (165 papers), Lymphoma Diagnosis and Treatment (144 papers) and Immunodeficiency and Autoimmune Disorders (58 papers). The work is most often cited by research in Genetics (10.5k citations), Pathology and Forensic Medicine (9.4k citations) and Hematology (3.8k citations). Emili Montserrat has collaborated with scholars based in Spain, Italy and United States. Frequent co-authors include Elı́as Campo, Neus Villamor, Dolors Colomer, Michael Hallek, Francesc Bosch, Armando López‐Guillermo, Peter Hillmen, Hartmut Döhner, Michael J. Keating and Federico Caligaris‐Cappio. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026